Third, the prevalence of 32.7% and 20.5% for NAFLD and NASH, respectively, are higher, because this study uses a CAP cutoff of 248 instead of 302, and AST and ALT cutoffs are 25 for both females and males, rather than 25 for females and 35 for males. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.